These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34432545)

  • 1. Teaching old mice new tricks: the utility of aged mouse models of C. difficile infection to study pathogenesis and rejuvenate immune response.
    Shin JH; Pawlowski SW; Warren CA
    Gut Microbes; 2021; 13(1):1966255. PubMed ID: 34432545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis.
    Jarchum I; Liu M; Shi C; Equinda M; Pamer EG
    Infect Immun; 2012 Sep; 80(9):2989-96. PubMed ID: 22689818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging impairs protective host defenses against Clostridioides (Clostridium) difficile infection in mice by suppressing neutrophil and IL-22 mediated immunity.
    Peniche AG; Spinler JK; Boonma P; Savidge TC; Dann SM
    Anaerobe; 2018 Dec; 54():83-91. PubMed ID: 30099125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microbiota and immune response during Clostridium difficile infection.
    Buonomo EL; Petri WA
    Anaerobe; 2016 Oct; 41():79-84. PubMed ID: 27212111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain.
    Pawlowski SW; Calabrese G; Kolling GL; Platts-Mills J; Freire R; AlcantaraWarren C; Liu B; Sartor RB; Guerrant RL
    J Infect Dis; 2010 Dec; 202(11):1708-12. PubMed ID: 20977342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice.
    Sadighi Akha AA; McDermott AJ; Theriot CM; Carlson PE; Frank CR; McDonald RA; Falkowski NR; Bergin IL; Young VB; Huffnagle GB
    Immunology; 2015 Apr; 144(4):587-97. PubMed ID: 25327211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection.
    Buonomo EL; Cowardin CA; Wilson MG; Saleh MM; Pramoonjago P; Petri WA
    Cell Rep; 2016 Jul; 16(2):432-443. PubMed ID: 27346351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microbiota and innate immunity in recurrent Clostridium difficile infection.
    Bibbò S; Lopetuso LR; Ianiro G; Di Rienzo T; Gasbarrini A; Cammarota G
    J Immunol Res; 2014; 2014():462740. PubMed ID: 24995345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice.
    McDermott AJ; Falkowski NR; McDonald RA; Pandit CR; Young VB; Huffnagle GB
    Immunology; 2016 Jan; 147(1):114-24. PubMed ID: 26455347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updating changes in human gut microbial communities associated with
    Herrera G; Paredes-Sabja D; Patarroyo MA; Ramírez JD; Muñoz M
    Gut Microbes; 2021; 13(1):1966277. PubMed ID: 34486488
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.
    Theriot CM; Koumpouras CC; Carlson PE; Bergin II; Aronoff DM; Young VB
    Gut Microbes; 2011; 2(6):326-34. PubMed ID: 22198617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease.
    Spinler JK; Brown A; Ross CL; Boonma P; Conner ME; Savidge TC
    Anaerobe; 2016 Aug; 40():54-7. PubMed ID: 27180007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.
    Nagao-Kitamoto H; Leslie JL; Kitamoto S; Jin C; Thomsson KA; Gillilland MG; Kuffa P; Goto Y; Jenq RR; Ishii C; Hirayama A; Seekatz AM; Martens EC; Eaton KA; Kao JY; Fukuda S; Higgins PDR; Karlsson NG; Young VB; Kamada N
    Nat Med; 2020 Apr; 26(4):608-617. PubMed ID: 32066975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse relapse model of Clostridium difficile infection.
    Sun X; Wang H; Zhang Y; Chen K; Davis B; Feng H
    Infect Immun; 2011 Jul; 79(7):2856-64. PubMed ID: 21576341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.
    Abernathy-Close L; Dieterle MG; Vendrov KC; Bergin IL; Rao K; Young VB
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32284366
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop.
    Hasegawa M; Kamada N; Jiao Y; Liu MZ; Núñez G; Inohara N
    J Immunol; 2012 Sep; 189(6):3085-91. PubMed ID: 22888139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin Receptor q223r Polymorphism Influences
    Horrigan O; Jose S; Mukherjee A; Sharma D; Huber A; Madan R
    Front Cell Infect Microbiol; 2021; 11():619192. PubMed ID: 33718269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
    mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.
    Frisbee AL; Saleh MM; Young MK; Leslie JL; Simpson ME; Abhyankar MM; Cowardin CA; Ma JZ; Pramoonjago P; Turner SD; Liou AP; Buonomo EL; Petri WA
    Nat Commun; 2019 Jun; 10(1):2712. PubMed ID: 31221971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.